3Manabe K, M atsui T, Yamaya M , et al. Sleep patterns and mortality among elderly patients in a geriatric hospiml[J]. Gerontology, 2000, 46(6): 318-322.
4Zeitlhofer J, Sehmeiser Rieder A ,Tribl G, et al. Sleep and quality of life in the Austrian population[J]. Aeta Neurol Seand, 2000, 102(4): 249-257.
5Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ,ventricular dysfunction [J]. Eur Heart J, 1999, 20 (24) : 1799-1807.
6Trachsel DS, Grenacher B, Weishaupt MA, et al. Plasma atrial natri- uretic peptide concentrations in horses with heart disease: a pilot study [J] . Vet J, 2012, 192 (2) : 166 -170.
7Chen Y, Wu Z, Yang C, et al. Investigation of atrial vulnerability by a- nalysis of the sinus node EG from atrial fibrillation models using a phase synchronization method[J]. IEEE Trans Biomed Eng, 2012, 59 (9) : 2668-2676.
8Olofsson SO, BorOn J. Apolipoprotein B: a clinically important apoli- poprotein which assembles atherogenic lipoproteins and promotes the de- velopment of atherosclerosis[J]. J Intern Med, 2005, 258 ( 5 ) : 395-410.
9Kato H, Mizuno T, Mizuno M, et al. Atrial'natriuretic peptide amelio-rates peritoneal fibrosis in rat peritonitis model [J]. Nephrol Dial Transplant, 2012, 27 (2) : 526-536.
10Martabe K,M atsui T,Yamaya M ,et al.Sleep patterns and mortality a- mong elderly patients in a geriatric hospiml[J].Gerontolog'y,2000,46 (6) : 318-322.
